Literature DB >> 26454653

Surgical stabilization of severe rib fractures decreases incidence of retained hemothorax and empyema.

Sarah Majercik1, Sathya Vijayakumar2, Griffin Olsen2, Emily Wilson3, Scott Gardner4, Steven R Granger4, Don H Van Boerum4, Thomas W White4.   

Abstract

BACKGROUND: Retained hemothorax (RH) is relatively common after chest trauma and can lead to empyema. We hypothesized that patients who have surgical fixation of rib fractures (SSRF) have less RH and empyema than those who have medical management of rib fractures (MMRF).
METHODS: Admitted rib fracture patients from January 2009 to June 2013 were identified. A 2:1 propensity score model identified MMRF patients who were similar to SSRF. RH, and empyema and readmissions, were recorded. Variables were compared using Fisher exact test and Wilcoxon rank-sum tests.
RESULTS: One hundred thirty-seven SSRF and 274 MMRF were analyzed; 31 (7.5%) had RH requiring 35 interventions; 3 (2.2%) SSRF patients had RH compared with 28 (10.2%) MMRF (P = .003). Four (14.3%) MMRF subjects with RH developed empyema versus zero in the SSRF group (P = .008); 6 (19.3%) RH patients required readmission versus 14 (3.7%) in the non-RH group (P = .002).
CONCLUSIONS: Patients with rib fractures who have SSRF have less RH compared with similar MMRF patients. Although not a singular reason to perform SSRF, this clinical benefit should not be overlooked.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Outcomes; Retained hemothorax; Rib fractures; Surgical stabilization of rib fractures; Thoracic trauma

Mesh:

Year:  2015        PMID: 26454653     DOI: 10.1016/j.amjsurg.2015.08.008

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

1.  Hemothorax: A Review of the Literature.

Authors:  Jacob Zeiler; Steven Idell; Scott Norwood; Alan Cook
Journal:  Clin Pulm Med       Date:  2020-01-10

Review 2.  Chest wall stabilization in trauma patients: why, when, and how?

Authors:  Jose Ribas Milanez de Campos; Thomas W White
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  Systematic review of systematic reviews for effectiveness of internal fixation for flail chest and rib fractures in adults.

Authors:  Helen Ma Ingoe; Elizabeth Coleman; William Eardley; Amar Rangan; Catherine Hewitt; Catriona McDaid
Journal:  BMJ Open       Date:  2019-04-01       Impact factor: 2.692

4.  Prosthetic-free ribs stabilization technique in critical complex chest wall traumas: first results and experiences.

Authors:  Paolo N C Girotti; Peter Tschann; Ingmar Königsrainer
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

5.  Rib fixation: Who, What, When?

Authors:  Marc de Moya; Ram Nirula; Walter Biffl
Journal:  Trauma Surg Acute Care Open       Date:  2017-04-27

6.  Early fixation versus conservative therapy of multiple, simple rib fractures (FixCon): protocol for a multicenter randomized controlled trial.

Authors:  Mathieu M E Wijffels; Jonne T H Prins; Suzanne Polinder; Taco J Blokhuis; Erik R De Loos; Roeland H Den Boer; Elvira R Flikweert; Albert F Pull Ter Gunne; Akkie N Ringburg; W Richard Spanjersberg; Pieter J Van Huijstee; Gust Van Montfort; Jefrey Vermeulen; Dagmar I Vos; Michael H J Verhofstad; Esther M M Van Lieshout
Journal:  World J Emerg Surg       Date:  2019-07-30       Impact factor: 5.469

7.  Surgical treatment ofpatients with severe non-flail chest rib fractures.

Authors:  Jian-Peng Zhang; Lin Sun; Wei-Qiang Li; Yan-Yu Wang; Xin-Zhen Li; Yang Liu
Journal:  World J Clin Cases       Date:  2019-11-26       Impact factor: 1.337

Review 8.  Blunt trauma related chest wall and pulmonary injuries: An overview.

Authors:  Bekir Nihat Dogrul; Ibrahim Kiliccalan; Ekrem Samet Asci; Selim Can Peker
Journal:  Chin J Traumatol       Date:  2020-04-20

9.  Outcome Analysis of Surgical Stabilization of Rib Fractures in Trauma Patients.

Authors:  Alexander A Fokin; Joanna Wycech; Russell Weisz; Ivan Puente
Journal:  J Orthop Trauma       Date:  2019-01       Impact factor: 2.512

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.